Buy opportunities have arisen
Eight trusts highlighted
Majority trading on a discount
Outlooks for the biotech sector
Technology must cut administrative burden
In the third part of a short series, managers tell Investment Week which value plays still look attractive after a strong run this year.
2016 saw several blow-ups for large drug companies